Evidence map›Paper›PMID 26635116›Full record

ArticleInflammation2016

Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism.

Yoichi Mashimo, Mika Sakurai-Yageta, Misa Watanabe, Takayasu Arima, Yoshinori Morita, Yuzaburo Inoue, Kazuki Sato, Toshiyuki Nishimuta, Shuichi Suzuki, Hiroko Watanabe and 8 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Acacetin Suppresses IL-1BioMed research international · 2020
    Article
  3. Article
  4. Biochemical and Biological Attributes of Matrix Metalloproteinases.Progress in molecular biology and translational science · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Yoichi MashimoDepartment of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.
Mika Sakurai-YagetaDepartment of Education and Training, Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryomachi, Aobaku, Sendai, 980-8573, Japan.
Misa WatanabeThe Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan.
Takayasu ArimaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoshinori MoritaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yuzaburo InoueDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kazuki SatoDepartment of Pediatrics, National Shimoshizu Hospital, Yotsukaido, Japan.
Toshiyuki NishimutaDepartment of Pediatrics, National Shimoshizu Hospital, Yotsukaido, Japan.
Shuichi SuzukiDepartment of Pediatrics, National Shimoshizu Hospital, Yotsukaido, Japan.
Hiroko WatanabeDepartment of Pediatrics, National Shimoshizu Hospital, Yotsukaido, Japan.
Akira HoshiokaDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Minako TomiitaDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Akiko YamaideDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Yoichi KohnoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoshitaka OkamotoDepartment of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Naoki ShimojoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Akira HataDepartment of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoichi SuzukiDepartment of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan. ysuzuki@megabank.tohoku.ac.jp.
Chiba University · JPShizuoka City Shimizu Hospital · JPChiba Hospital · JPTohoku University · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) are a class of extra-cellular and membrane-bound proteases involved in a wide array of physiological and pathological processes including tissue remodeling, inflammation, and cytokine secretion and activation. MMP-13 has been shown to be involved in lung diseases such as acute lung injury, viral infections, and chronic obstructive pulmonary disease; however, the molecular pathogenesis of MMP-13 in these conditions is not well understood. In this study, we investigated the mechanisms and roles of MMP-13 secretion in human small airway epithelial cells (SAECs) and functional polymorphisms of the MMP13 gene. Polyinosinic-polycytidylic acid (poly(I:C)) and interferon β (IFN-β) stimulated the secretion of MMP-13 from SAECs by more than several hundred-fold. Stimulation of the secretion by poly(I:C) was abolished by SB304680 (p38 inhibitor), LY294002 (PI3K inhibitor), Janus kinase (JAK) inhibitor I, RNA-activated protein kinase (PKR) inhibitor, and Bay 11-7082 (NF-κB inhibitor), while stimulation by IFN-β was inhibited by all except Bay 11-7082. These data suggested that the secretion of MMP-13 was mediated through IFN receptor pathways independently of nuclear factor kappa B (NF-κB) and that poly(I:C) stimulated IFN secretion in an NF-κB-dependent manner from SAECs, leading to IFN-stimulated MMP-13 secretion. Chemical MMP-13 inhibitors and MMP-13 small interfering RNA (siRNA) inhibited IFN-stimulated secretion of interferon gamma-inducible protein 10 (IP-10) and regulated on activation, normal T-cell expressed and secreted (RANTES), suggesting that MMP-13 is involved in the secretion of these virus-induced proinflammatory chemokines. We identified a novel functional polymorphism in the promoter region of the MMP13 gene. The MMP13 gene may play important roles in defense mechanisms of airway epithelial cells.

Indexed as

Polymorphism, GeneticBronchiCells, CulturedChemokinesEpithelial CellsHumansInterferon-betaInterferonsMatrix Metalloproteinase 13NF-kappa BPoly I-CPromoter Regions, GeneticTranscriptional ActivationChemokinesInterferon-betaInterferonsMatrix Metalloproteinase 13MMP13 protein, humanNF-kappa BPoly I-Cairway epithelial cellcollagenase 3gene expressioninfectioninterferron betamatrix metalloproteinase 13polymorphism

Identifiers

PMID26635116
OpenAlexW2185415655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.